Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method of purifying proteins

A protein, protein technology, applied in the field of protein purification

Inactive Publication Date: 2015-10-07
CSL BEHRING AG
View PDF9 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, while endogenous Hp and Hx control the side effects of free Hb / hemoglobin under physiological steady-state conditions, they maintain steady-state Hb / hemoglobin levels under pathophysiological conditions such as those associated with hemolysis. little effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method of purifying proteins
  • A method of purifying proteins
  • A method of purifying proteins

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0134] Starting material: Cohn fraction IV was used 4 The precipitate was used as starting material for the purification of haptoglobin, hemopexin, and transferrin (see figure 1 ).

[0135] Precipitation extraction: by introducing 20 g extraction buffer / g Fraction IV 4 Precipitate (20x extraction rate), an extraction of the precipitate was performed. Mix the buffer and pellet for at least 1 h. Extraction buffer consisted of 50 mM Tris adjusted to pH 7.0 with concentrated HCl. Prepare the extraction buffer at a temperature of 20-25 °C. Precipitation extraction was also carried out at a temperature of 20-25°C. During the 1 hour extraction time, the pH during extraction was maintained at 7.0 to 8.0 (preferably 7.0).

[0136] Ammonium sulfate precipitation: to fraction IV 4 Solid ammonium sulfate is added to the extract in order to obtain a final concentration of 2.0 to 2.5M (preferably 2.4M). Ammonium sulfate was slowly added to the extract with stirring and mixing was co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates generally to a method of purifying proteins. More specifically, the present inventions relates to a method of purifying haptoglobin and hemopexin from the same starting material, and uses thereof.

Description

technical field [0001] The present invention generally relates to a method of purifying proteins. More particularly, the present invention relates to a method for purifying haptoglobin and hemopexin from the same starting material, and uses thereof. Background technique [0002] Hemolysis is characterized by the destruction of red blood cells and is a hall-mark of anemic conditions associated with red blood cell abnormalities, such as enzyme deficiencies, hemoglobinopathies, hereditary spherocytosis, paroxysmal nocturnal hemoglobinuria, and spinous erythrocytes (spur cell) anemia, and exogenous factors such as splenomegaly, autoimmune disorders (eg, hemolytic disease of the newborn), genetic disorders (eg, sickle cell disease or G6PD deficiency), microangiopathic hemolysis, genetic Lambert-positive bacterial infections (eg, streptococci, enterococci, and staphylococci), parasitic infections (eg, Plasmodium), toxins, and trauma (eg, burns). Hemolysis is also a common transf...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/79C07K1/14C07K1/16C07K1/30C07K1/36C07K14/47
CPCC07K1/14C07K1/16C07K1/30C07K1/36C07K14/79C07K14/4717C07K14/805A61P13/02A61P13/12A61P17/02A61P33/06A61P35/02A61P37/02A61P37/06A61P7/00A61P7/04A61P7/06Y02A50/30C07K1/18A61K38/1722A61K38/42
Inventor N·布林克曼
Owner CSL BEHRING AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com